News
-
According to RDD Online, the RDD China meeting scheduled to take place October 16-18, 2013 in Beijing has been cancelled due to “contractual problems which made it impossible for RDD to guarantee the quality of… Read more . . .
-
Inhaled pharmaceuticals company Prosonix has announced the appointment of Columbia Laboratories President and CEO Frank Condella as a Non-executive Director of Prosonix. Condella has held numerous position in the pharmaceutical industry, including as CEO of… Read more . . .
-
Avanir Pharmaceuticals has paid $20 million up front to OptiNose for an exclusive North American license for development and commercialization of OptiNose’s intranasal low-dose sumatriptan powder for the treatment of acute migraines. OptiNose could receive… Read more . . .
-
Jabil Circuit has announced the completion of its $665 million acquisition of contract plastics manufacturer Nypro, which makes dry powder inhalers and nasal spray pumps for pharmaceutical companies among other products. According to Jabil, it… Read more . . .
-
Acorda Therapeutics announced results from a clinical study of the pharmacokinetics, safety, and tolerability of its diazepam nasal spray for the treatment of cluster seizures in epilepsy patients at the recent International Congress of the… Read more . . .
-
According to Insmed, a Phase 3 study of more than 300 cystic fibrosis patients has demonstrated the non-inferiority of once-daily Arikace inhaled liposomal amikacin to twice-daily TOBI tobramycin inhalation solution, meeting the study’s primary endpoint.… Read more . . .
-
Zogenix has announced that it has reached an agreement with Valeant to begin selling Migranal dihydroergotamine mesylate nasal spray in the US beginning in late July 2013 and extending initially through the end of 2015.… Read more . . .
-
The Australia Research Council (ARC) has awarded a $370,000 Linkage grant to Paul Young, Daniela Traini, and Brian Oliver of RespiTech and the cell biology group at the Woolcock Institute of Medical Research (WIMR) for… Read more . . .
-
The 2nd article in a 3-part series . . . Read more Read more . . .
-
Alexza Pharmaceuticals has announced the appointment of Michael S. Holfinger as Vice President, Manufacturing & Global Supply Chain Management. Holfinger was most recently Vice President, Manufacturing & CMC Development at Affymax. Alexza recently announced that… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK